Amarin | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
AbbVie USD 3.32B 2.71B 2024-12
Alnylam Pharmaceuticals USD 67.09M 34.73M 2024-12
Amarin USD 531.38M 20.5M 2024-09
AstraZeneca USD 40.87B 66M 2024-12
DBV Technologies USD 27.4M 26.63M 2024-12
GlaxoSmithKline GBP 13.67B 218M 2024-12
Halozyme Therapeutics USD 363.82M 88.88M 2024-12
Ionis Pharmaceuticals USD 588.35M 74.12M 2024-12
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Novartis USD 44.05B 605M 2024-12



Amarin Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.